<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0" xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" xmlns:media="http://search.yahoo.com/mrss/">
  <channel>
    <title>Hey Colleagues - Latest immunotherapy brain cancer News &amp; Blogs</title>
    <link>https://www.heycolleagues.com/topic/immunotherapy%20brain%20cancer</link>
    <description>Stay updated with the latest immunotherapy brain cancer articles, blogs, and stories from Hey Colleagues</description>
    <language>en-US</language>
    <lastBuildDate>Tue, 22 Jul 2025 10:44:49 GMT</lastBuildDate>
    <managingEditor>heycolleagues@gmail.com (Hey Colleagues)</managingEditor>
    <webMaster>heycolleagues@gmail.com (Hey Colleagues)</webMaster>
    <ttl>15</ttl>
    <generator>Keynate Topic RSS Generator</generator>
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.heycolleagues.com/topic/immunotherapy%20brain%20cancer/rss" rel="self" type="application/rss+xml" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" href="https://www.heycolleagues.com/topic/immunotherapy%20brain%20cancer" rel="alternate" type="text/html" />
    <atom:link xmlns:atom="http://www.w3.org/2005/Atom" rel="hub" href="https://pubsubhubbub.appspot.com/" />
    <image>
      <title>Hey Colleagues - Latest immunotherapy brain cancer News &amp; Blogs</title>
      <url>https://www.heycolleagues.com/apple-touch-icon.png</url>
      <link>https://www.heycolleagues.com/topic/immunotherapy%20brain%20cancer</link>
      <width>96</width>
      <height>96</height>
    </image>
    <item>
      <title>Breakthrough Trends in Glioblastoma Immunotherapy: A Data-Centered Look</title>
      <link>https://www.heycolleagues.com/news/breakthrough-trends-in-glioblastoma-immunotherapy-a-data-centered-look</link>
      <description>&lt;a href="https://www.heycolleagues.com/news/breakthrough-trends-in-glioblastoma-immunotherapy-a-data-centered-look"&gt;&lt;img alt="Breakthrough Trends in Glioblastoma Immunotherapy: A Data-Centered Look" src="https://www.heycolleagues.com/view/world/GmQf2mza4AALRPA.jpg"&gt;&lt;/a&gt;&lt;p&gt;A data-driven analysis of glioblastoma immunotherapy, spotlighting survival rates, clinical trial outcomes, and a potential game-changer in cancer care from the UK.&lt;/p&gt;</description>
      <category>glioblastoma survival data</category>
      <category>brain tumor immunotherapy</category>
      <category>ipilimumab outcomes</category>
      <category>cancer trial statistics</category>
      <category>UK glioblastoma trial</category>
      <category>immunotherapy brain cancer</category>
      <category>survival rate glioblastoma</category>
      <category>new glioblastoma treatments</category>
      <pubDate>Tue, 22 Jul 2025 10:44:49 GMT</pubDate>
      <guid>https://www.heycolleagues.com/news/breakthrough-trends-in-glioblastoma-immunotherapy-a-data-centered-look</guid>
    </item>
  </channel>
</rss>
